drugset / Trial / NCT00537953
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
RandomizedParallel-groupOpen-labelTreatment
Summary
The combination of a half-course of miltefosine and a half-course of antimony will be evaluated for efficacy and tolerance. The combination of miltefosine and antimony is chosen because these are now the two standard agents in Bolivia, and in vitro the combination was additive to mildly synergistic against a standard leishmania strain.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meglumine antimonate | Other / unclassified | — | — |
| Subject | Miltefosine | Small molecule | — | Oral |